Abbott Labs (ABT)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Abbott Labs | ABT | Healthcare | Medical Devices | 95 | 11.5% |
| Current Price (10/04) | $103.08 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 45,548.0 | |||
| Sales Growth Forecast | 6.3% | |||
| Net Profit Margin | 23.5% | |||
| Projected Shares Outstanding | 1,759.38 | |||
| EPS - Five year Forecast | $8.27 | |||
| Average P/E Ratio | 20.0 | |||
| Projected Average Price | $165.41 | |||
| Price Appreciation (Annualized) | 9.9% | |||
| Annual Dividend Yield | 1.6% | |||
| Projected Annual Return | 11.5% | |||
| Quality | ||||
| Financial Strength | 99 | 24.8 | ||
| EPS Stability | 94 | 23.5 | ||
| Industry Sales Growth Rate | 11.5% | 6.9 | ||
| Industry Net Profit Margin | 15.5% | 19.0 | ||
| Calculated Quality Rating | 75.6 | |||
| Fool CAPS | ||||
Total Players
2484
Outperforms
97
Underperforms
All-Stars (508)
495
Outperforms (97%)
13
Underperforms
|
||||
| Fundamental Data Updated: 08/12/2022 | ||||